Escitalopram and Depression in Elderly Alzheimer's Patients

An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimer's Disease

To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.

This study will assess the efficacy, tolerability, and safety of escitalopram in the treatment of Major Depressive Disorder in patients with Alzheimer's disease over a 24-week period. It will also assess the efficacy and tolerability of escitalopram after 12 weeks of treatment.

Inclusion Criteria:

• > 50 years
• Male & female
• Alzheimer's disease
• Depressive episode